Significantly, our findings also indicate that inflammatory signaling, and sensitivity to TLR4 stimulation, was enhanced in PBMCs of patients with RR-MS, highlighting that TLR4 may play a role at least in the RR form of MS pathogenesis. Here, TLR4 is linked to myeloid sarcoma.